Author Details
Written By
MMST, MBBS
Reviewed By
MD Pharmacology, MBBS
Last updated
05 Dec 2023 | 06:14 PM (IST)

We provide you with authentic, trustworthy and relevant information

Want to know more

Have issue with the content?

Report Problem

Memcad 0.125mg Tablet


Product introduction

Memcad 0.125mg Tablet is a medicine used to control bleeding from the uterus, that may occur after childbirth or an abortion. It works on the smooth muscle of the uterus and increases tone, rate, and amplitude of contractions thus reduces blood loss.

Memcad 0.125mg Tablet induces a rapid and sustained effect on muscles of womb which shortens the third stage of labor and reduces blood loss

Uses of Memcad Tablet

  • Post-delivery bleeding

Benefits of Memcad Tablet

In Post-delivery bleeding

Memcad 0.125mg Tablet helps to control excessive bleeding after giving birth. This helps to prevent severe loss of blood that can lead to dropping of blood pressure, shock and even death if not controlled in time. It helps proper contraction of the uterus and therefore prevents hemorrhage and further complications.

Side effects of Memcad Tablet

Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them

Common side effects of Memcad

  • High blood pressure
  • Headache
  • Seizure

How to use Memcad Tablet

Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Memcad 0.125mg Tablet may be taken with or without food, but it is better to take it at a fixed time.

Safety advice

Alcohol
CONSULT YOUR DOCTOR
It is not known whether it is safe to consume alcohol with Memcad 0.125mg Tablet. Please consult your doctor.
Pregnancy
UNSAFE
Memcad 0.125mg Tablet is highly unsafe to use during pregnancy. Seek your doctor's advice as studies on pregnant women and animals have shown significant harmful effects to the developing baby.
Breast feeding
CAUTION
Memcad 0.125mg Tablet should be used with caution during breastfeeding. Breastfeeding should be held until the treatment of the mother is completed and the drug is eliminated from her body.
Driving
CONSULT YOUR DOCTOR
It is not known whether Memcad 0.125mg Tablet alters the ability to drive. Do not drive if you experience any symptoms that affect your ability to concentrate and react.
Kidney
CONSULT YOUR DOCTOR
There is limited information available on the use of Memcad 0.125mg Tablet in patients with kidney disease. Please consult your doctor.
Liver
CONSULT YOUR DOCTOR
There is limited information available on the use of Memcad 0.125mg Tablet in patients with liver disease. Please consult your doctor.

All substitutes

For informational purposes only. Consult a doctor before taking any medicines.
Memcad 0.125mg Tablet
₹4.7/Tablet
Methergin Tablet
Novartis India Ltd
₹8.87/tablet
89% costlier
Utergin 0.125mg Tablet
Maneesh Pharmaceuticals Ltd
₹8.85/tablet
88% costlier
Ergolin 0.125mg Tablet
Lincoln Pharmaceuticals Ltd
₹7.92/tablet
69% costlier
Mergin 0.125mg Tablet
Shrinivas Gujarat Laboratories Pvt Ltd
₹8.17/tablet
74% costlier
Methygin 0.125mg Tablet
Intas Pharmaceuticals Ltd
₹8.05/tablet
71% costlier

Quick tips

  • Memcad 0.125mg Tablet is used for the prevention and control of post-delivery bleeding.
  • It may also be used for the active management of the third stage of labor, to facilitate the delivery of the placenta.
  • It should be avoided in patients, with high blood pressure, and heart disease.

Fact Box

Chemical Class
Ergolines
Habit Forming
No
Therapeutic Class
GYNAECOLOGICAL
Action Class
Uterotonic and abortificient

Patient concerns

arrow
Lower back pain post delivery.
Dr. Akshat Goel
Orthopaedics
Do Hot fomentation and Apply Dynapar QPS spray Take Tab Myospas-D twice daily and Cap Nurokind-Gold twice daily and Cap Pansec-DSR once daily empty stomach for 4 days
Post delivery lots of illness
Dr. Pushkar Mani
Physician
Kindly refer to gyanecologist
arrow

FAQs

Should Memcad 0.125mg Tablet be taken with or without food?

Take Memcad 0.125mg Tablet orally with or without food as directed by your doctor, usually 3 to 4 times daily for up to 1 week after delivery. Dosage is based on your medical condition and response to treatment. Always follow your doctor's advice while taking Memcad 0.125mg Tablet.

Who should not take Memcad 0.125mg Tablet?

Memcad 0.125mg Tablet should not be taken by individuals who have a history of high blood pressure, heart disease, liver disease, kidney disease, or a history of seizures. It should also not be taken by pregnant women, as it can cause contractions of the uterus.

Can Memcad 0.125mg Tablet be used during breastfeeding?

Memcad 0.125mg Tablet can pass into breast milk and may harm a nursing infant. It is recommended to wait at least 12 hours after taking Memcad 0.125mg Tablet before breastfeeding.

Does Memcad 0.125mg Tablet increase blood pressure?

Yes, one of the most common adverse effects of Memcad 0.125mg Tablet is hypertension along with seizure. Seek immediate medical help in such a case.

Can Memcad 0.125mg Tablet be given to patients with heart disease?

Patients with risk factors for coronary artery disease (e.g., smoking, obesity, diabetes, high cholesterol) if administered Memcad 0.125mg Tablet, are more susceptible to heart blockage leading to severe complications.

Want to share the information?

Disclaimer:

Tata 1mg's sole intention is to ensure that its consumers get information that is expert-reviewed, accurate and trustworthy. However, the information contained herein should NOT be used as a substitute for the advice of a qualified physician. The information provided here is for informational purposes only. This may not cover everything about particular health conditions, lab tests, medicines, all possible side effects, drug interactions, warnings, alerts, etc. Please consult your doctor and discuss all your queries related to any disease or medicine. We intend to support, not replace, the doctor-patient relationship.

References

  1. Medscape. Methylergonovine. [Accessed 03 Apr. 2019] (online) Available from:External Link
  2. Methylergometrine. East Hanover, New Jersey: Novartis Pharmaceuticals Corporation; 2012. [Accessed 03 Apr. 2019] (online) Available from:External Link

Marketer details

Name: Zydus Cadila
Address: Zydus Tower, Satellite Cross Roads,Ahmedabad – 380015 Gujarat, India.
Country of origin: India

MRP
47
Inclusive of all taxes
10.0 tablets in 1 strip
SOLD OUT
Notify me

INDIA’S LARGEST HEALTHCARE PLATFORM

LegitScript approved

downArrow